Basilea Pharmaceutica(CH:BSLN)
CHF 71.00-0.20 (-0.28%)
CH:BSLN
Basilea Pharmaceutica Revenue
CHF 71.00
At close:-0.20 (-0.28%)
Want to see CH:BSLN full AI Analyst Report?
Basilea Pharmaceutica (BSLN) Revenue
9 Followers
Basilea Pharmaceutica Revenue
Basilea Pharmaceutica had a revenue of 119.00M in the quarter ending Jun 30, 2026, with -7.35%. This bring the company's revenue in the last twelve months to 247.44M, Increased 37.14%. In the fiscal year ending Dec 31, 2025, Basilea Pharmaceutica had annual revenue of 232.40M with 11.44% growth.
- Revenue (ttm)
- 247.44M
- Revenue Growth
- 4.74%
- P/S Ratio
- 3.77
- Revenue/Employee
- CHF 1,162,000
- Employees
- 200
- Market Cap
- CHF 876.50M
Revenue Chart
Basilea Pharmaceutica Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 232.40M | 23.86M | 11.44% |
| Dec 31, 2024 | 208.54M | 50.91M | 32.30% |
| Dec 31, 2023 | 157.63M | 9.87M | 6.68% |
| Dec 31, 2022 | 147.76M | -357.00K | -0.24% |
| Dec 31, 2021 | 148.12M | 20.49M | 16.06% |
| Dec 31, 2020 | 127.63M | -6.75M | -5.02% |
| Dec 31, 2019 | 134.38M | 1.83M | 1.38% |
| Dec 31, 2018 | 132.56M | 31.03M | 30.57% |
| Dec 31, 2017 | 101.52M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.